UFP Technologies Announces Q3 Results


NEWBURYPORT, Mass., Nov. 02, 2016 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq:UFPT), an innovative designer and custom converter of foams, plastics, and natural fiber materials, today reported net income of $2.7 million or $0.37 per diluted common share outstanding for its third quarter ended September 30, 2016, compared to net income of $2.0 million or $0.28 per diluted common share outstanding for the same period in 2015.  Sales for the third quarter were $37.2 million, 8.1% higher than third quarter sales of $34.4 million in 2015.  Net income for the nine-month period ended September 30, 2016 was $6.5 million or $0.89 per diluted common share outstanding compared to $5.9 million or $0.82 per diluted common share outstanding for the same 2015 period.  Sales for the nine-month period ended September 30, 2016 were $109.6 million compared to sales of $104.9 million for the same period in 2015.

“We continue to make solid progress on a number of fronts,” said R. Jeffrey Bailly, Chairman & CEO.  “We increased revenue by 8% in Q3, led by a nearly 20% rise in medical sales. Net income increased 34%, as a $1.7 million settlement for raw material overcharges more than offset manufacturing inefficiencies related to our plant consolidations and some one-time expenses incurred during the quarter.”

“As we work to re-qualify parts affected by these consolidations, our focus remains on delivering high-quality parts on time and bringing new programs online smoothly,” Bailly continued.  “Initiatives to streamline our manufacturing processes will follow, and we anticipate significant efficiency improvements once our consolidation and re-qualification efforts are complete.”

“With a robust pipeline of new growth opportunities, the addition of new sales and engineering talent, and strong operational synergies still to be realized, we remain bullish about our future,” said Bailly.

UFP Technologies is an innovative designer and custom converter of foams, plastics, and natural fiber materials, principally serving the medical, automotive, consumer, electronics, industrial, and aerospace and defense markets. The UFP team acts as an extension of its customers’ in-house research, engineering, and manufacturing groups, working closely with them to solve their most complex product and packaging challenges.

This news release contains statements relating to expected financial performance and/or future business prospects, events and plans that are forward-looking statements.  Such statements include, but are not limited to, statements about the Com­pany’s prospects, statements about the Company’s acquisition strategies and opportunities, statements regarding new hires and anticipated trends in the different markets in which the Company competes, anticipated advantages relating to the Company’s decisions to consolidate its facilities and the expected cost savings and efficiencies associated therewith, anticipated advantages and the timing associated with requalification of parts, anticipated advantages of maintaining fewer, larger plants, anticipated advantages the Company expects to realize from its investments and capital expenditures, expectations regarding the manufacturing capacity and efficiencies of the Company, statements about the Company’s participation and growth in multiple markets, its business opportunities, the Company’s growth potential and strategies for growth, anticipated revenues and the timing of such revenues, and any indication that the Company may be able to sustain or increase its sales and earnings or sales and earnings growth rates.  Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation risks and uncertainties associated with the identification of suitable ac­quisition candidates and the successful, efficient execution of acquisition transactions and integration of any such acquisition candi­dates, risks and uncertainties associated with plant closures and expected efficiencies from consolidating manufacturing, risks that the Company may not be able to finalize anticipated new customer contracts, risks associated with the implementation of new production equipment and requalification or recertification of transferred equipment, in a timely, cost-efficient manner, risks that any benefits from such new or transferred equipment may be delayed or not fully realized, or that the Company may be unable to fully utilize its expected production capacity, as well as other risks and uncertainties that are detailed in the documents filed by the Company with the Securities and Exchange Commission (“SEC”).  Accordingly, actual results may differ materially.  Readers are referred to the documents filed by the Company with the SEC, specifically the last reports on Forms 10-K and 10-Q.  The forward-looking statements contained herein speak only of the Company’s expecta­tions as of the date of this press release.  The Company express­ly disclaims any obligation or undertaking to release publicly any updates or revi­sions to any such statement to reflect any change in the Company’s expectations or any change in events, conditions, or circumstances on which any such statement is based.

 

Consolidated Condensed Statements of Income
(in thousands, except per share data)
(unaudited)
 
  Three Months Ended Nine Months Ended
  September 30, September 30,
   2016   2015   2016   2015 
         
Net sales $  37,220  $  34,441  $  109,626  $  104,917 
Cost of sales    28,768     24,931   83,161   76,475 
Gross profit    8,452     9,510     26,465     28,442 
SG&A    6,027     5,604   18,402   18,404 
Restructuring costs    25     851   203   959 
Material overcharge settlement    (1,681)    -   (2,114)    - 
Gain on sale of fixed assets    -     -   (4)  (31)
Operating income    4,081     3,055     9,978     9,110 
Interest income (expense), net    25     9   51   (7)
Income before income taxes    4,106     3,064     10,029     9,103 
Income taxes    1,437     1,072   3,550   3,186 
Net income from consolidated operations $  2,669  $  1,992  $  6,479  $  5,917 
         
Net income per share outstanding $  0.37  $  0.28  $  0.90  $  0.83 
Net income per diluted share outstanding $  0.37  $  0.28  $  0.89  $  0.82 
         
Weighted average shares outstanding  7,225   7,131   7,213   7,108 
Weighted average diluted shares outstanding  7,312   7,230   7,294   7,212 
 

 


Consolidated Condensed Balance Sheets
(in thousands)
 
  September 30, December 31,
   2016   2015 
Assets: (unaudited)  
Cash $  30,118  $  29,804 
Receivables    22,307     17,481 
Inventories    14,568     14,202 
Other current assets    2,642     2,116 
Net property, plant, and equipment    48,762     46,555 
Other assets    9,646     9,792 
Total assets $  128,043  $  119,950 
Liabilities and equity:    
Short-term debt $  1,028  $  1,011 
Accounts payable    5,106     4,598 
Other current liabilities    5,372     5,374 
Long-term debt    84     859 
Other liabilities    4,965     4,536 
Total liabilities    16,555     16,378 
Total equity    111,488     103,572 
Total liabilities and stockholders' equity $  128,043  $  119,950 
     

            

Coordonnées